DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Biapenem is an investigational drug.
There have been 4 clinical trials for Biapenem. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2017.
The most common disease conditions in clinical trials are Bacterial Infections, Neoplasm Metastasis, and [disabled in preview]. The leading clinical trial sponsors are Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company), Alphacait, LLC, and Haining Health-Coming Biotech Co., Ltd.
There are eight hundred and eighty US patents protecting this investigational drug and five international patents.
Recent Clinical Trials for Biapenem
|Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor||Alphacait, LLC||Phase 2|
|Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor||Haining Health-Coming Biotech Co., Ltd.||Phase 2|
|Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination||Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||Phase 1|
Top disease conditions for Biapenem
Top clinical trial sponsors for Biapenem
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Biapenem||⤷ Try it Free||Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders||Dana-Farber Cancer Institute, Inc. (Boston, MA)||⤷ Try it Free|
|Biapenem||⤷ Try it Free||Cyclic boronic acid ester derivatives and methods of making the same||Rempex Pharmaceuticals, Inc. (San Diego, CA)||⤷ Try it Free|
|Biapenem||⤷ Try it Free||Methods of treating inflammation associated airway diseases and viral infections||WASHINGTON STATE UNIVERSITY (Pullman, WA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX)||⤷ Try it Free|
|Biapenem||⤷ Try it Free||Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same||PharmaIN Corporation (Bothell, WA)||⤷ Try it Free|
|Biapenem||⤷ Try it Free||Inhibitors of metallo-.beta.-lactamase-enzymes||McMaster University (Hamilton, CA)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Biapenem||Australia||AU2011210567||2030-01-29||⤷ Try it Free|
|Biapenem||Canada||CA2787784||2030-01-29||⤷ Try it Free|
|Biapenem||European Patent Office||EP2528893||2030-01-29||⤷ Try it Free|
|Biapenem||European Patent Office||EP3138838||2030-01-29||⤷ Try it Free|
|Biapenem||Japan||JP2013518816||2030-01-29||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|